Here, we extend these previous reports not only by increasing the number of the patients (1497 patients), but also by comprehensive genetic analysis of exonic and small nucleotide mutations and immunostaining of dystrophin on muscle biopsies to deduce genotype-phenotype correlations in patients with dystrophinopathies. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.